- Home
- AGIO vs HGTY Comparison
AGIO vs HGTY Comparison
Compare AGIO & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGIO | HGTY |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGIO | HGTY |
|---|---|---|
| Price | $26.54 | $12.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $32.13 | $13.83 |
| AVG Volume (30 Days) | ★ 2.7M | 107.0K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 241.11 |
| EPS | N/A | ★ 0.36 |
| Revenue | $44,791,000.00 | ★ $1,360,017,000.00 |
| Revenue This Year | $28.75 | $18.41 |
| Revenue Next Year | $139.45 | N/A |
| P/E Ratio | ★ N/A | $36.07 |
| Revenue Growth | ★ 36.26 | 17.92 |
| 52 Week Low | $22.24 | $8.03 |
| 52 Week High | $46.00 | $13.86 |
Technical Indicators
Market Signals| Indicator | AGIO | HGTY |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 52.64 |
| Support Level | $26.80 | $12.38 |
| Resistance Level | $28.61 | $13.60 |
| Average True Range (ATR) | 1.17 | 0.33 |
| MACD | 0.26 | -0.07 |
| Stochastic Oscillator | 5.65 | 41.77 |
Price Performance
Historical ComparisonAbout AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.